Review on Respiratory Syncytial Virus Infection among Older Adults and Transplant Recipients

Abstract

Children frequently contract respiratory syncytial virus (RSV), which is also more and more indicated as one of the significant respiratory pathogens in immunocompromised hosts and older adults. RSV could exacerbate underlying lung and heart conditions in elderly adults (1). Also, it might be linked to acute rejection as well as chronic lung allograft malfunction amongst lung transplant recipients (LTRs), along with considerable mortalities and morbidities in hematopoietic stem cell transplant (HSCT) and solid organ transplant (SOT) recipients. There are currently few choices for treating severe RSV, and there is less information on how to manage RSV in older adults(2). RSV in older adults, SOT recipients, and HSCT recipients is thoroughly discussed in this study. Since nosocomial dissemination was documented, infection control and prevention techniques are essential to preventing epidemics. Developing monoclonal antibodies for immunoprophylaxis, antivirals, and vaccines is ongoing, although more study is still required in such crucial fields(3).